Martha Romero

Martha Romero

Auto-generated profile, based on publicly available information

Martha Romero

Hospital Universitario Fundacion Santa Fe de Bogota, Bogota, Colombia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2024 in Frontiers in Hematology
Verified
Journal Article
Open access
MRMartha Romero
Martha Romero
AOAdrián Mosquera Orgueira
Adrián Mosquera Orgueira
MSMateo Mejía Saldarriaga
Mateo Mejía Saldarriaga
Multiple myeloma is the second most frequent hematologic malignancy worldwide with high morbidity and mortality. Although it is considered an incurable disease, the enhanced understanding of this neoplasm has led to new treatments, which have improved patients’ life expectancy. Large amounts of data have been generated through different studies in the settings of clinical trials, prospective registries, and real-world cohorts, which have incorporated laboratory tests, flow cytometry, molecular markers, cytogenetics, diagnostic images, and therapy into routine clinical practice. In this review, we described how these data can be processed and analyzed using different models of artificial intelligence, aiming to improve accuracy and translate into clinical benefit, allow a substantial improvement in early diagnosis and response evaluation, speed up analyses, reduce labor-intensive process prone to operator bias, and evaluate a greater number of parameters that provide more precise information. Furthermore, we identified how artificial intelligence has allowed the development of integrated models that predict response to therapy and the probability of achieving undetectable measurable residual disease, progression-free survival, and overall survival leading to better clinical decisions, with the potential to inform on personalized therapy, which could improve patients’ outcomes. Overall, artificial intelligence has the potential to revolutionize multiple myeloma care, being necessary to validate in prospective clinical cohorts and develop models to incorporate into routine daily clinical practice.

31 March 2016 in Colombia Medica
Verified
Journal Article
Open access
PDF file
MRMartha Romero
Martha Romero
GGGuido R. González-Fontal
Guido R. González-Fontal
MDMónica Duarte
Mónica Duarte
CSCarlos Saavedra
Carlos Saavedra
AHAndrés F. Henao-Martínez
Andrés F. Henao-Martínez
Case Description:An 82-years old Hispanic woman with a past medical history significant for pulmonary thromboembolism on oral anticoagulation, rheumatoid arthritis, and hypertension developed a new onset thrombocytopenia.Clinical Findings:Small clonal B-cells populations (SCBP) also known as monoclonal B-cell lymphocytosis was found as part of the workup for an idiopathic thrombocytopenia and lead ultimately to the diagnosis of parotid primary follicular lymphoma coexisting with Warthin tumor involving the bone marrow in a small extent and oncocytic papilloma located in the maxillary sinus.Treatment and Outcome:Patient was treated with Rituximab monotherapy with improvement on her platelet count.Clinical relevance:Although it is unclear the role of this clonal cells, they may work as a possible diagnostic tool for occult lymphomas. Further prospective studies are needed to confirm this possible association.

24 October 2023 in Journal of Cancer Education
Verified
Journal Article
Closed access
PDF file
JGJuan Guio
Juan Guio
AMAndrés Melo
Andrés Melo
MSMateo Mejía Saldarriaga
Mateo Mejía Saldarriaga
CFCynthia Fuentes
Cynthia Fuentes
NTNatalia Tíjaro-Ovalle
Natalia Tíjaro-Ovalle
MRMartha Romero
Martha Romero

21 September 2023 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
LCLaura Baldovino Chiquillo
Laura Baldovino Chiquillo
DRDaniela Lucía Rico
Daniela Lucía Rico
DLDrixie Dalyla Leal
Drixie Dalyla Leal
MRMartha Romero
Martha Romero
A female patient in her 30s presented to the emergency department with a 10-day history of fever, weakness and diaphoresis. Subsequent investigations revealed a diagnosis of haemophagocytic syndrome, secondary to disseminated non-tuberculous mycobacterial infection affecting the bone marrow, lungs, lymph nodes and skin. The bone marrow culture confirmed the presence of Mycobacterium avium infection. The patient’s haemophagocytic syndrome was managed using the HLH-2004 chemoimmunotherapy, and M. avium infection was treated with a combination of clarithromycin, ethambutol, rifampicin, ciprofloxacin and amikacin. Throughout her hospitalisation, the patient faced several serious complications arising from both the medications and the prolonged hospital stay (lasting 12 months). However, these complications were promptly identified and effectively managed through a multidisciplinary and comprehensive approach. This approach was crucial in achieving a favourable patient outcome and successful recovery.

30 July 2024 in IDCases
Verified
Journal Article
Open access
JVJavier A. Baena-Del Valle
Javier A. Baena-Del Valle
Sergio D. Cruz-RomeroSergio D. Cruz-Romero
Sergio D. Cruz-Romero
MRMartha L. Romero-Prieto
Martha L. Romero-Prieto
AFAdriana A. Flórez-Vargas
Adriana A. Flórez-Vargas
DPDiana M. Palacios-Ortiz
Diana M. Palacios-Ortiz
MPMauricio A. Palau-Lázaro
Mauricio A. Palau-Lázaro
Cytomegalovirus (CMV) can cause a broad range of diseases, with severity depending on immune status, comorbidities, and age. Initial CMV infection usually occurs in childhood and is typically asymptomatic, leading to lifelong latency. In immunocompromised patients, CMV can affect multiple organs, but salivary gland infections are rare. This study presents a case of a 66-year-old woman with B-cell acute lymphoblastic leukemia who developed swelling and pain in the right preauricular region during pre-transplant consolidation therapy. Despite a recent bone marrow biopsy indicating morphological remission and a flow cytometry analysis detecting only 0.04 % B lymphoblasts, she exhibited these symptoms. A CT scan revealed enlargement, hyperdensity, and enhancement of the right parotid glands, with accompanying subcutaneous edema. A biopsy of the right parotid gland showed a dense interstitial lymphoplasmacytic infiltrate with numerous Cowdry bodies and smaller granular cytoplasmic inclusions, all testing positive for CMV immunohistochemistry. The findings confirm the diagnosis of CMV sialadenitis in an immunocompromised patient. This case underscores the importance of considering CMV infections in similar clinical scenarios, particularly in patients with compromised immune systems.

5 December 2024 in Revista Colombiana de Hematología y Oncología
Verified
Journal Article
Open access
PDF file
RORocío Orduz
Rocío Orduz
JRJavier Rendón
Javier Rendón
MRMartha Romero
Martha Romero
SQSandra Quijano
Sandra Quijano
ICIsabella Caicedo-Ortiz
Isabella Caicedo-Ortiz
CCCarlos Alberto Castro
Carlos Alberto Castro
The hematolymphoid neoplasms are considered to be of high cost and have an impact on quality of life, for this reason the use of diagnostic and tests for follow-up such as Measurable Residual Disease (MRD) continues to be a tool to determine prognoses, considering new technologies and the importance of standardizing processing. Objective: To structure a series of considerations by common agreement of experts about Measurable Residual Disease in 5 hematological pathologies, in the Colombian context. Methods: A formal consensus of experts, mixed (Delphi/Nominal), was made from 23 context questions related to Measurable Residual Disease in 5 hematological pathologies. 2 qualifying rounds and a virtual nominal meeting were held. The information was analyzed in STATA 13. Results: 23 questions related to the diagnosis of Measurable Residual Disease in 5 hematological pathologies were constructed in the context of its use in Colombia. 17 health professionals (pathology and bacteriology) experts in Measurable Residual Disease by flow cytometry from Bogotá, Medellín, Cali, Bucaramanga, Cartagena, Rionegro, Barranquilla and Cúcuta participated and it was leading by the Colombian Association of Hematology and Oncology (ACHO). Conclusions: 23 considerations were defined to guide the use of flow cytometry for Measurable Residual Disease in 5 hematological pathologies, as well as to make a diagnosis of the context of this test in Colombia. Finally, this consensus aims to standardize this technique as well standardize clinical conducts between hemato-oncologists hoping to improve the decisions that are taken because this measurement in order to improve health´s patients.